Related Experiment Video
Updated: Aug 26, 2026

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model
Published on: October 16, 2017
Gene and protein expression of RCAS1 in hepatocellular carcinoma
Masahide Ikeguchi1, Yasuaki Hirooka, Nobuaki Kaibara
1Division of Operating Room, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago 683-8504, Japan. masaike@grape.med.tottori-u.ac.jp
Background:
RCAS1 (receptor-binding cancer antigen expressed on SiSo cells) is expressed on the tumor cell membrane and induces apoptosis in infiltrated lymphocytes. In the present study, the clinical importance of RCAS1 gene and protein expression were analyzed in surgically resected hepatocellular carcinomas (HCCs).
Patients And Methods:
RCAS1 gene and protein expression levels were evaluated and compared with clinical findings in 60 patients with HCC. Expression levels of RCAS1 messenger RNA (mRNA) from tumors was analyzed quantitatively by real-time reverse transcriptase polymerase chain reaction (RT-PCR). RCAS1 protein expression was analyzed by immunohistochemistry and the percentage of RCAS1-positive cancer cells was counted in each case.
Results:
RCAS1 messenger RNA levels significantly positively correlated with protein expression levels. RCAS1 protein expression was detected in 75% of cases and high RCAS1 immunoreactivity was detected in 19 tumors (31.7%). RCAS1 protein expression did not correlate with tumor differentiation, progression, nor disease-free survival. New tumors developed in the residual livers after resection of primary tumors in 39 patients. Treatment with transcatheter arterial embolization (TAE) from hepatic artery was performed in these patients. Survival periods after TAE treatment in these patients were analyzed. The mean survival period of 13 patients who had primary tumors with high RCAS1 protein expression (41.4 months) was significantly longer than that of 26 patients with low expression (23.5 months, p = 0.024). After TAE treatment, a low expression level of RCAS1 protein in primary tumors was recognized as a poor prognostic factor independently of tumor stage, by multivariate analysis, in patients who had developed new tumors in the residual livers.
Conclusion:
RCAS1 protein expression in primary tumor may be a good marker for the effectiveness of TAE treatment in patients who develop new tumors in the residual livers.
Insights
Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) protein levels in primary hepatocellular carcinoma (HCC) tumors predict transcatheter arterial embolization (TAE) effectiveness. High RCAS1 expression indicates better survival after TAE for new tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Hepatobiliary Surgery
Background:
- Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is a tumor-associated antigen expressed on hepatocellular carcinoma (HCC) cell membranes.
- RCAS1 expression can induce apoptosis in tumor-infiltrating lymphocytes, potentially impacting anti-tumor immunity.
- The clinical significance of RCAS1 in HCC, particularly its correlation with treatment outcomes, requires further investigation.
Purpose of the Study:
- To analyze the clinical importance of RCAS1 gene and protein expression in surgically resected HCC.
- To evaluate the correlation between RCAS1 expression levels and patient survival, especially after transcatheter arterial embolization (TAE) for recurrent tumors.
- To determine if RCAS1 expression can serve as a prognostic marker for HCC patients undergoing TAE.
Main Methods:
- RCAS1 gene and protein expression were quantified in 60 HCC patients using real-time RT-PCR and immunohistochemistry.
- Expression levels were correlated with clinicopathological features, including tumor differentiation, progression, and disease-free survival.
- Survival analysis was performed for patients who developed new tumors and received TAE, stratifying by RCAS1 expression levels.
Main Results:
- RCAS1 mRNA and protein expression levels showed a significant positive correlation.
- RCAS1 protein was detected in 75% of HCC cases, with high immunoreactivity in 31.7%.
- High RCAS1 protein expression in primary tumors was associated with significantly longer survival (41.4 months) after TAE compared to low expression (23.5 months) in patients with new tumor development (p = 0.024).
Conclusions:
- RCAS1 protein expression in primary HCC tumors is not correlated with tumor differentiation or progression.
- Low RCAS1 protein expression in primary tumors is an independent poor prognostic factor for patients who develop new tumors after initial resection.
- RCAS1 protein expression may serve as a valuable predictive marker for the effectiveness of TAE treatment in HCC patients with recurrent disease.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Cell Specific Gene Expression
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
